Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Catalent Inc (CTLT)

119.67   -0.16 (-0.13%) 01-20 23:02
Open: 119.88 Pre. Close: 119.83
High: 120.18 Low: 118.16
Volume: 830,815 Market Cap: 19,709M
Catalent, Inc., together with its subsidiaries, provides delivery technologies and development solutions for drugs, biologics, and consumer and animal health products worldwide. It operates through four segments: Softgel and Oral Technologies, Biologics, Oral and Specialty Delivery, and Clinical Supply Services. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products, such as prescription drugs, over-the-counter medications, dietary supplements, unit-dose cosmetics, and animal health medicinal preparations. The Biologics segment provides biologic cell-line; develops and manufactures cell therapy and viral vector gene therapy; formulation, development, and manufacturing for parenteral dose forms, including prefilled syringes, vials, and cartridges; and analytical development and testing services. The Oral and Specialty Delivery segment offers formulation, development, and manufacturing across a range of technologies along with integrated downstream clinical development and commercial supply solutions. This segment also offers oral delivery solutions platform comprising pre-clinical screening, formulation, analytical development, and current good manufacturing practices services. The Clinical Supply Services segment offers manufacturing, packaging, storage, distribution, and inventory management for drugs and biologics clinical trials. It also offers FastChain demand-led clinical supply services. The company serves pharmaceutical, biotechnology, and consumer health companies; and companies in other healthcare market segments, such as animal health and medical devices, as well as in cosmetics industries. It has a collaboration with the Janssen Pharmaceutical Companies; Arcturus Therapeutics Holdings Inc.; and BrainStorm Cell Therapeutics Inc. Catalent, Inc. was founded in 2007 and is headquartered in Somerset, New Jersey.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 120.249 - 120.863 120.863 - 121.334
Low: 116.722 - 117.371 117.371 - 117.868
Close: 118.641 - 119.731 119.731 - 120.568

Technical analysis

as of: 2021-01-20 4:46:00 PM
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 140.37     One year: 163.95
Support: Support1: 105.10    Support2: 95.79
Resistance: Resistance1: 120.18    Resistance2: 140.37
Pivot: 110.79
Moving Average: MA(5): 117.00     MA(20): 109.18
MA(100): 96.01     MA(250): 78.98
MACD: MACD(12,26): 4.89     Signal(9): 3.89
Stochastic oscillator: %K(14,3): 94.58     %D(3): 90.12
RSI: RSI(14): 80.01
52-week: High: 120.48  Low: 31.04  Change(%): 94.4
Average Vol(K): 3-Month: 120393  10-Days: 104376

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
CTLT has closed below upper band by 13.2%. Bollinger Bands are 86% wider than normal. The large width of the bands suggest high volatility as compared to CTLT's normal range. The bands have been in this wide range for 5 bars. This is a sign that the current trend might continue.

Headline News

Wed, 20 Jan 2021
Catalent, Inc. Announces Second Quarter Fiscal Year 2021 Earnings Conference Webcast - Yahoo Finance

Tue, 19 Jan 2021
Catalent, Inc. (NYSE:CTLT) Given Consensus Recommendation of "Buy" by Analysts - MarketBeat

Mon, 18 Jan 2021
Why Catalent (CTLT) is Poised to Beat Earnings Estimates Again - Nasdaq

Mon, 18 Jan 2021
Is Catalent (NYSE:CTLT) Using Too Much Debt? - Simply Wall St

Thu, 14 Jan 2021
Catalent, Inc. (NYSE:CTLT) Short Interest Update - MarketBeat

Sun, 10 Jan 2021
The Catalent (NYSE:CTLT) Share Price Has Soared 363%, Delighting Many Shareholders - Yahoo Finance

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Outperform
Return on Equity: Neutral Debt to Equity: Outperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NYSE
Sector:  Healthcare
Industry:  Drug Manufacturers General Specialty & Generic
Shares Out. (M) 165
Shares Float (M) 164
% Held by Insiders 0.59
% Held by Institutions 100.28
Shares Short (K) 1,870
Shares Short P. Month (K) 1,330

Stock Financials

EPS 1.580
EPS Est This Year 1.630
EPS Est Next Year 1.820
Book Value (p.s.) 18.660
Profit Margin 9.25
Operating Margin 14.03
Return on Assets (ttm) 4.1
Return on Equity (ttm) 10.2
Qtrly Rev. Growth 27.2
Gross Profit (p.s.) 5.970
Sales Per Share 19.915
EBITDA (p.s.) 4.383
Qtrly Earnings Growth 82300.00
Operating Cash Flow (M) 565
Levered Free Cash Flow (M) -12

Stock Valuations

PE Ratio 75.74
PEG Ratio 3.26
Price to Book value 6.41
Price to Sales 6.01
Price to Cash Flow 34.90

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.